Upgrade to SI Premium - Free Trial

Immunovant, Inc. (IMVT) Misses Q1 EPS by 1c

August 11, 2025 11:02 AM

Immunovant, Inc. (NASDAQ: IMVT) reported Q1 EPS of ($0.71), $0.01 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.

Categories

Earnings